These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1242 related articles for article (PubMed ID: 17334511)

  • 1. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ticlopidine on von Willebrand factor-mediated shear-induced platelet activation and aggregation.
    Goto S; Tamura N; Sakakibara M; Ikeda Y; Handa S
    Platelets; 2001 Nov; 12(7):406-14. PubMed ID: 11674857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dependence of platelet thrombus stability on sustained glycoprotein IIb/IIIa activation through adenosine 5'-diphosphate receptor stimulation and cyclic calcium signaling.
    Goto S; Tamura N; Ishida H; Ruggeri ZM
    J Am Coll Cardiol; 2006 Jan; 47(1):155-62. PubMed ID: 16386680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor.
    Cauwenberghs N; Schlammadinger A; Vauterin S; Cooper S; Descheemaeker G; Tornai I; Deckmyn H
    Thromb Haemost; 2001 Apr; 85(4):679-85. PubMed ID: 11341505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor.
    Lepäntalo A; Virtanen KS; Reséndiz JC; Mikkelsson J; Viiri LE; Karhunen PJ; Lassila R
    Thromb Res; 2009 Jun; 124(2):193-8. PubMed ID: 19232433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease.
    Storey RF; Wilcox RG; Heptinstall S
    Platelets; 2002 Nov; 13(7):407-13. PubMed ID: 12487788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of arterial thrombosis by intravenously administered platelet P2T receptor antagonist AR-C69931MX in a canine model.
    Huang J; Driscoll EM; Gonzales ML; Park AM; Lucchesi BR
    J Pharmacol Exp Ther; 2000 Nov; 295(2):492-9. PubMed ID: 11046080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI.
    Penz S; Reininger AJ; Brandl R; Goyal P; Rabie T; Bernlochner I; Rother E; Goetz C; Engelmann B; Smethurst PA; Ouwehand WH; Farndale R; Nieswandt B; Siess W
    FASEB J; 2005 Jun; 19(8):898-909. PubMed ID: 15923400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional significance of adenosine 5'-diphosphate receptor (P2Y(12)) in platelet activation initiated by binding of von Willebrand factor to platelet GP Ibalpha induced by conditions of high shear rate.
    Goto S; Tamura N; Eto K; Ikeda Y; Handa S
    Circulation; 2002 May; 105(21):2531-6. PubMed ID: 12034661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease.
    Heptinstall S; Espinosa DI; Manolopoulos P; Glenn JR; White AE; Johnson A; Dovlatova N; Fox SC; May JA; Hermann D; Magnusson O; Stefansson K; Hartman D; Gurney M
    Platelets; 2008 Dec; 19(8):605-13. PubMed ID: 19012178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostacyclin receptor stimulation facilitates detection of human platelet P2Y(12) receptor inhibition by the PFA-100 system.
    Kobsar AL; Koessler J; Rajkovic MS; Brunner KP; Steigerwald U; Walter U
    Platelets; 2010; 21(2):112-6. PubMed ID: 20085435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of P2Y12 receptor antagonists on TRAP-induced platelet aggregation, procoagulant activity, microparticle formation and intracellular calcium responses in patients with acute coronary syndromes.
    Behan MW; Fox SC; Heptinstall S; Storey RF
    Platelets; 2005 Mar; 16(2):73-80. PubMed ID: 15823862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation.
    Lecut C; Schoolmeester A; Kuijpers MJ; Broers JL; van Zandvoort MA; Vanhoorelbeke K; Deckmyn H; Jandrot-Perrus M; Heemskerk JW
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1727-33. PubMed ID: 15231520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole blood.
    Storey RF; Newby LJ; Heptinstall S
    Platelets; 2001 Nov; 12(7):443-7. PubMed ID: 11674863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The P2Y12 receptor as a therapeutic target in cardiovascular disease.
    Storey RF
    Platelets; 2001 Jun; 12(4):197-209. PubMed ID: 11454254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
    Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
    Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors.
    Baurand A; Eckly A; Bari N; Léon C; Hechler B; Cazenave JP; Gachet C
    Thromb Haemost; 2000 Sep; 84(3):484-91. PubMed ID: 11019976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic treatment with acetylsalicylic acid and clopidogrel on atheroprogression and atherothrombosis in ApoE-deficient mice in vivo.
    Schulz C; Konrad I; Sauer S; Orschiedt L; Koellnberger M; Lorenz R; Walter U; Massberg S
    Thromb Haemost; 2008 Jan; 99(1):190-5. PubMed ID: 18217153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of P2Y(1) and P2Y(12) receptor antagonists on ADP-induced shape change of equine platelets: comparison with human platelets.
    Mateos-Trigos G; Evans RJ; Heath MF
    Platelets; 2002; 13(5-6):285-92. PubMed ID: 12189014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.